Diagnos Laboratorium Utama Tbk. vs Salim Ivomas Pratama Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Salim Ivomas Pratama Tbk. trades at Rp545 (market cap 8.53T, 3.68M 24h volume). The key difference: Salim Ivomas Pratama Tbk. is far larger — about 27.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Salim Ivomas Pratama Tbk. is more actively traded (3.68M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | SIMP | |
|---|---|---|
Market Cap | 310.75B | 8.53T |
Volume | 963.6K | 3.68M |
Lot | 9.64K | 36.77K |
Turnover | 217.67M | 2B |
Average Price | 225.89 | 543.76 |
Value | 217.67M | 2B |
Indicative Equilibrium Price | 226 | 545 |
Indicative Equilibrium Volume | 1K | 1.19K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Salim Ivomas Pratama Tbk (the company) was established under its original name of PT Ivomas Pratama base on notarial deed No.65 of Mrs Maria Kidarsa, S.H, dated on 12 Aug, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 46 of Benny Kristianto, S.H., dated Dec 14, 2010, concerning among others, the change in the Company’s name, par value and public offering.
Read more on SIMP →